Considering the recent discoveries; it would be a lot easier for a small company like RAC to commercialise an Anthracyclene/Decitabine/PD1 synergiser than a stand alone salvage chemotherapeutic or FTO inhibitor.
I still think we're gone shortly after any positive readouts in the EM AML/MDS trial (registered as a liquid tumour agent/Decitabine synergiser - not just one cancer indication).
- Forums
- ASX - By Stock
- RAC
- RAC media coverage
RAC media coverage, page-720
-
-
- There are more pages in this discussion • 1,545 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.81 |
Change
-0.030(1.63%) |
Mkt cap ! $308.2M |
Open | High | Low | Value | Volume |
$1.88 | $1.89 | $1.80 | $88.27K | 48.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 80 | $1.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.82 | 4500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 80 | 1.810 |
1 | 9623 | 1.800 |
1 | 10000 | 1.790 |
3 | 6646 | 1.780 |
1 | 16000 | 1.775 |
Price($) | Vol. | No. |
---|---|---|
1.815 | 1500 | 1 |
1.845 | 1884 | 2 |
1.850 | 4458 | 1 |
1.890 | 300 | 1 |
1.900 | 2589 | 1 |
Last trade - 10.46am 24/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online